University Clinic of Pulmonary and Allergic Diseases Golnik
Golnik, 4204, Slovenia
NCT Number: NCT02009319
The aim of this pilot study is to evaluate EBUS elastography strain ratio in assessment of mediastinal lymph nodes in patients with suspicion for lung cancer for the first time. Strain ratios of mediastinal lymph nodes will be compared with EBUS B-mode features and with tissue diagnosis as a gold standard.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Golnik, 4204, Slovenia
Evaluation will be performed on consenting consecutive patients at least 18 years old, referred to bronchoscopy with suspicion for lung cancer according to chest CT-scan. Eligible patients should have either enlarged discrete N2/N3 lymph nodes, or central tumor or enlarged N1 lymph nodes with normal mediastinal lymph nodes. Exclusion criteria will be metastatic disease, severe co-morbidity that disqualified surgical treatment, mediastinal infiltration by tumor and small peripheral lung tumor with normal-sized mediastinal lymph nodes.
Outcomes: Sensitivity, specificity, accuracy, positive predictive value (PPV) and negative predictive value (NPV) for probability of malignant lymph node diagnosis, determined by elastography strain ratio. Receiver operating characteristic (ROC) analysis will be made to display specificity / sensitivity for different strain ratio cut-off values. Area under the ROC curve will be calculated.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: up to 7 months
Sensitivity, specificity, accuracy, positive predictive value (PPV) and negative predictive value (NPV)
The University Clinic of Pulmonary and Allergic Diseases Golnik
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04354246
Adnexal Diseases, Advanced Cancer
Sarasota, Florida, United States
View Trial DetailsNCT06389981
Lung Cancer, Lung Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT05794607
Lung Cancer, Lung Diseases
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT03337399
Lung Cancer, Lung Diseases
Boston, Massachusetts, United States
View Trial Details